Goldspan Health review

Goldspan Health presents a prescription catalog through an Altro-hosted clinical platform. Its public category pages link to the actual Goldspan product listings there, where the selected offer and charge interval are shown. The catalog spans GLP-1s, NAD+, sermorelin, glutathione, topical copper peptide and hormone therapies. The platform terms distinguish Goldspan from the medical group and pharmacy services. A clinician decides whether to prescribe after reviewing the medical intake. A wide catalog can help compare service arrangements, but it does not establish that every product improves longevity, sleep, cognition or body composition.

The charge interval is explicit on the reviewed semaglutide, tirzepatide, NAD+, sermorelin and copper-peptide product pages: the option labeled monthly is billed every twenty-eight days. This differs from calendar-month billing. The selected NAD+ comparison is about $216.18 per annualized calendar month, while copper-peptide cream is about $161.86 on the same comparison basis. The amount charged every twenty-eight days remains separate from that calculation. An annualized equivalent is not a promise about how many cash payments fall within a particular first year; that depends on the start date and charge schedule.

Clinical care is described as a medical-history review, with a short video consultation when the history or location requires it. Product timelines estimate review in one to two business days, followed by pharmacy preparation and shipping. Those stages should not be collapsed into delivery two days after checkout. Automatic refills and optional check-ins for dose personalization are described on the reviewed product pages. A patient should still confirm which follow-up is required for their prescription, what happens if a check-in or laboratory result is late and how to contact the assigned clinician. A general clinical-team description does not guarantee that a specific advisor provides every consultation.

Laboratory requirements vary by treatment. The homepage calls labs optional and encouraged, while the current GLP-1 product pages require testing sixty to ninety days after starting and annually afterward. They allow a patient to obtain the panel through another provider and upload results. An optional dose-adjustment questionnaire is therefore different from an optional required lab panel. Hormone listings also identify recent-laboratory requirements for particular treatments. Confirm the exact panel, timing, whether existing results are acceptable and its separate cost before paying. The clinical review, medication and shipping bundle should not be presented as universally including every future laboratory expense.

The public catalog currently includes more than the weight-loss category alone, with separately listed full-dose and microdose GLP-1s, topical hormone products and progesterone. A small or needle-free formulation should not be assumed to have the same evidence, absorption or outcome as an approved branded product or a different injection. Compounded medicines are not FDA-approved finished products. Goldspan says it does not sell research-use-only material and describes dispensing through licensed pharmacy arrangements, but that is a company disclosure rather than verification of a particular order or batch. Ask for the actual dispensing pharmacy, location and preparation before shipment, and confirm authorization for your address.

The refund policy says an order is generally final once placed. Its stated exception is a clinician declining the requested treatment after reviewing the intake, which qualifies for a full refund. Product pages also allow pausing, delaying or canceling a subscription, but that should be understood as managing future orders rather than an automatic reversal of an already placed prescription order. Lost or damaged shipments should be reported within seven days of delivery under the stated replacement process. Confirm the next renewal date, the cutoff for stopping processing and the effective cancellation date in writing. A cancel-anytime statement and a final-sale prescription policy answer different questions.